0001070081-19-000009.txt : 20190109
0001070081-19-000009.hdr.sgml : 20190109
20190109170930
ACCESSION NUMBER: 0001070081-19-000009
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190107
FILED AS OF DATE: 20190109
DATE AS OF CHANGE: 20190109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Peltz Stuart Walter
CENTRAL INDEX KEY: 0001578962
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 19518750
MAIL ADDRESS:
STREET 1: PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
4
1
wf-form4_154707175413809.xml
FORM 4
X0306
4
2019-01-07
0
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001578962
Peltz Stuart Walter
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
1
1
0
0
Chief Executive Officer
Common Stock
2019-01-07
4
S
0
1764
34.75
D
24882
D
Common Stock
2019-01-07
4
S
0
339
34.75
D
17947
I
By Spouse
Common Stock
2019-01-07
4
S
0
409
34.75
D
17538
I
By Spouse
Stock Option (Right To Buy)
451.2
2019-05-15
Common Stock
41.0
41
I
By Spouse
Stock Option (Right To Buy)
1149.6
2020-02-02
Common Stock
37.0
37
I
By Spouse
Stock Option (Right To Buy)
490.8
2021-04-27
Common Stock
58.0
58
I
By Spouse
Stock Option (Right To Buy)
218.4
2022-01-10
Common Stock
38.0
38
I
By Spouse
Stock Option (Right To Buy)
10.85
2023-05-15
Common Stock
3900.0
3900
I
By Spouse
Stock Option (Right To Buy)
27.05
2024-01-28
Common Stock
4900.0
4900
I
By Spouse
Stock Option (Right To Buy)
51.0
2025-01-02
Common Stock
10880.0
10880
I
By Spouse
Stock Option (Right To Buy)
30.86
2026-01-03
Common Stock
11000.0
11000
I
By Spouse
Stock Option (Right To Buy)
12.64
2026-11-16
Common Stock
2000.0
2000
I
By Spouse
Stock Option (Right To Buy)
11.23
2027-01-02
Common Stock
12600.0
12600
I
By Spouse
Stock Option (Right To Buy)
18.01
2028-01-02
Common Stock
30625.0
30625
I
By Spouse
Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 5,400 shares of restricted stock from a January 3, 2017 grant of 21,600 shares of restricted stock.
Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 975 RSUs from a January 3, 2017 grant of 3,900 RSUs.
Includes: 1) 1,950 unvested RSUs from an award of 3,900 RSUs granted on January 3, 2017, which vests in four equal annual installments over four years, commencing on January 3, 2018; and 2) 5,250 shares of restricted stock granted on January 3, 2018, which vest in four equal annual installments over four years, commencing on January 3, 2019.
The reporting person acquired beneficial ownership of these securities upon his marriage to the owner of the securities in 2018.
Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 1,312 shares of restricted stock from a January 3, 2018 grant of 5,250 shares of restricted stock.
Currently exercisable.
This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
This option was granted on November 17, 2016 and vests over four years, with 25% of the shares underlying the option vesting on November 17, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on February 17, 2018.
This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.
This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.
/s/ Avraham S. Adler, attorney-in-fact
2019-01-09